LIRA and SEMA gained approval from the Food and Drug Administration and the European Medicines Agency for weight loss in obese individuals or people who are overweight with BMI 27 kg/m 2 and have experienced at least one weight-associated comorbid condition (such as prediabetes, hypertension, dyslipidaemia, and OSA) combined with lifestyle modifications [63]
They do not replace advice from a qualified researcher or physician
J Neurosci 36(23):61656174 Jander S, Schroeter M, Peters O, Witte OW, Stoll G (2001) Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain
(2) in the preparation of the product, auxiliary materials such as crystal skeleton propping agent and the like are not added, and the prepared product can obtain a final product with the loading capacity and the appearance meeting the requirements, thereby eliminating the product quality risk caused by adding the auxiliary materials and improving the medication safety